Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Kepler Vision spots UvA Ventures in $2.1m round

University of Amsterdam-founded Kepler Vision has secured capital from investors including UvA Ventures to commercialise body language recognition products.


Mar 31, 2018

Symbiotix secures Harvard licences

Symbiotix has licensed more Harvard IP to propel the commercialisation of T-cell modulators based on studies of the human microbiome.

Mar 29, 2018

Circular Wave coils together $2m seed round

The Ohio State spinout raised an additional $900,000 to advance its speed control gear technology for industrial robots.

Mar 29, 2018

Metalysis casts $17m round

Several existing shareholders including Woodford have returned to back a $17m funding round for Metalysis, which produces metal powders for 3D printing.

Mar 29, 2018

Vanderbilt to benefit from $65m partnership

Deerfield Management and Vanderbilt University have launched Ancora Innovation with $65m in capital to support early-stage life science research and back resulting spinouts.

Mar 29, 2018

CTT touches on Parkwalk investment

Parkwalk has invested from two vehicles under its management after previously backing the Cambridge spinout in late 2016.

Mar 28, 2018

Axcend arises out of BYU

Axcend hoppes to release a portable liquid chromatograph that has a high sensitivity and is compatible with various web-enabled devices.

Mar 27, 2018

Myriota orbits $15m series A

Nanosatellite internet of things technology developer Myriota has attracted $15m in series A funding from investors co-led by Main Sequence Ventures.

Mar 27, 2018

Big deal: NMD flexes series A muscles

Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.

Mar 26, 2018

Dracen collects $40m series A

The Johns Hopkins spinout will funnel the cash into developing a class of glutamine antagonist that could help treat cancer.

Mar 26, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here